Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Echtrosept is a natural oral rinse developed by Weber & Weber Biologische Arzneimittel, primarily indicated for daily oral hygiene and the supportive treatment of inflammatory conditions of the oral mucosa and gums, such as gingivitis and stomatitis. The formulation is based on a combination of botanical extracts, including *Echinacea purpurea*, sage (*Salvia officinalis*), chamomile (*Chamomilla recutita*), and myrrh (*Commiphora myrrha*). These components provide a synergistic therapeutic profile characterized by antimicrobial, anti-inflammatory, and astringent properties. Echtrosept works by soothing irritated tissues, reducing gum bleeding, and inhibiting the growth of pathogens in the oral cavity, thereby promoting the healing of minor lesions and maintaining overall periodontal health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Echtrosept (Weber & Weber).